Current File : /var/www/html/digiprint/public/site/go8r5d/cache/c07f8ba6d5e7d13d77a5724839aa7ff3
a:5:{s:8:"template";s:9437:"<!DOCTYPE html>
<html lang="en">
<head>
<meta charset="utf-8"/>
<meta content="width=device-width, initial-scale=1.0" name="viewport"/>
<title>{{ keyword }}</title>
<link href="//fonts.googleapis.com/css?family=Open+Sans%3A300%2C400%2C600%2C700%2C800%7CRoboto%3A100%2C300%2C400%2C500%2C600%2C700%2C900%7CRaleway%3A600%7Citalic&subset=latin%2Clatin-ext" id="quality-fonts-css" media="all" rel="stylesheet" type="text/css"/>
<style rel="stylesheet" type="text/css"> html{font-family:sans-serif;-webkit-text-size-adjust:100%;-ms-text-size-adjust:100%}body{margin:0}footer,nav{display:block}a{background:0 0}a:active,a:hover{outline:0}@media print{*{color:#000!important;text-shadow:none!important;background:0 0!important;box-shadow:none!important}a,a:visited{text-decoration:underline}a[href]:after{content:" (" attr(href) ")"}a[href^="#"]:after{content:""}p{orphans:3;widows:3}.navbar{display:none}}*{-webkit-box-sizing:border-box;-moz-box-sizing:border-box;box-sizing:border-box}:after,:before{-webkit-box-sizing:border-box;-moz-box-sizing:border-box;box-sizing:border-box}html{font-size:62.5%;-webkit-tap-highlight-color:transparent}body{font-family:"Helvetica Neue",Helvetica,Arial,sans-serif;font-size:14px;line-height:1.42857143;color:#333;background-color:#fff}a{color:#428bca;text-decoration:none}a:focus,a:hover{color:#2a6496;text-decoration:underline}a:focus{outline:thin dotted;outline:5px auto -webkit-focus-ring-color;outline-offset:-2px}p{margin:0 0 10px}ul{margin-top:0;margin-bottom:10px}.container{padding-right:15px;padding-left:15px;margin-right:auto;margin-left:auto}@media (min-width:768px){.container{width:750px}}@media (min-width:992px){.container{width:970px}}@media (min-width:1200px){.container{width:1170px}}.container-fluid{padding-right:15px;padding-left:15px;margin-right:auto;margin-left:auto}.row{margin-right:-15px;margin-left:-15px}.col-md-12{position:relative;min-height:1px;padding-right:15px;padding-left:15px}@media (min-width:992px){.col-md-12{float:left}.col-md-12{width:100%}}.collapse{display:none} .nav{padding-left:0;margin-bottom:0;list-style:none}.nav>li{position:relative;display:block}.nav>li>a{position:relative;display:block;padding:10px 15px}.nav>li>a:focus,.nav>li>a:hover{text-decoration:none;background-color:#eee}.navbar{position:relative;min-height:50px;margin-bottom:20px;border:1px solid transparent}@media (min-width:768px){.navbar{border-radius:4px}}@media (min-width:768px){.navbar-header{float:left}}.navbar-collapse{max-height:340px;padding-right:15px;padding-left:15px;overflow-x:visible;-webkit-overflow-scrolling:touch;border-top:1px solid transparent;box-shadow:inset 0 1px 0 rgba(255,255,255,.1)}@media (min-width:768px){.navbar-collapse{width:auto;border-top:0;box-shadow:none}.navbar-collapse.collapse{display:block!important;height:auto!important;padding-bottom:0;overflow:visible!important}}.container-fluid>.navbar-collapse,.container-fluid>.navbar-header{margin-right:-15px;margin-left:-15px}@media (min-width:768px){.container-fluid>.navbar-collapse,.container-fluid>.navbar-header{margin-right:0;margin-left:0}}.navbar-brand{float:left;height:50px;padding:15px 15px;font-size:18px;line-height:20px}.navbar-brand:focus,.navbar-brand:hover{text-decoration:none}@media (min-width:768px){.navbar>.container-fluid .navbar-brand{margin-left:-15px}}.navbar-nav{margin:7.5px -15px}.navbar-nav>li>a{padding-top:10px;padding-bottom:10px;line-height:20px}@media (min-width:768px){.navbar-nav{float:left;margin:0}.navbar-nav>li{float:left}.navbar-nav>li>a{padding-top:15px;padding-bottom:15px}.navbar-nav.navbar-right:last-child{margin-right:-15px}}@media (min-width:768px){.navbar-right{float:right!important}}.clearfix:after,.clearfix:before,.container-fluid:after,.container-fluid:before,.container:after,.container:before,.nav:after,.nav:before,.navbar-collapse:after,.navbar-collapse:before,.navbar-header:after,.navbar-header:before,.navbar:after,.navbar:before,.row:after,.row:before{display:table;content:" "}.clearfix:after,.container-fluid:after,.container:after,.nav:after,.navbar-collapse:after,.navbar-header:after,.navbar:after,.row:after{clear:both}@-ms-viewport{width:device-width}html{font-size:14px;overflow-y:scroll;overflow-x:hidden;-ms-overflow-style:scrollbar}@media(min-width:60em){html{font-size:16px}}body{background:#fff;color:#6a6a6a;font-family:"Open Sans",Helvetica,Arial,sans-serif;font-size:1rem;line-height:1.5;font-weight:400;padding:0;background-attachment:fixed;text-rendering:optimizeLegibility;overflow-x:hidden;transition:.5s ease all}p{line-height:1.7;margin:0 0 25px}p:last-child{margin:0}a{transition:all .3s ease 0s}a:focus,a:hover{color:#121212;outline:0;text-decoration:none}.padding-0{padding-left:0;padding-right:0}ul{font-weight:400;margin:0 0 25px 0;padding-left:18px}ul{list-style:disc}ul>li{margin:0;padding:.5rem 0;border:none}ul li:last-child{padding-bottom:0}.site-footer{background-color:#1a1a1a;margin:0;padding:0;width:100%;font-size:.938rem}.site-info{border-top:1px solid rgba(255,255,255,.1);padding:30px 0;text-align:center}.site-info p{color:#adadad;margin:0;padding:0}.navbar-custom .navbar-brand{padding:25px 10px 16px 0}.navbar-custom .navbar-nav>li>a:focus,.navbar-custom .navbar-nav>li>a:hover{color:#f8504b}a{color:#f8504b}.navbar-custom{background-color:transparent;border:0;border-radius:0;z-index:1000;font-size:1rem;transition:background,padding .4s ease-in-out 0s;margin:0;min-height:100px}.navbar a{transition:color 125ms ease-in-out 0s}.navbar-custom .navbar-brand{letter-spacing:1px;font-weight:600;font-size:2rem;line-height:1.5;color:#121213;margin-left:0!important;height:auto;padding:26px 30px 26px 15px}@media (min-width:768px){.navbar-custom .navbar-brand{padding:26px 10px 26px 0}}.navbar-custom .navbar-nav li{margin:0 10px;padding:0}.navbar-custom .navbar-nav li>a{position:relative;color:#121213;font-weight:600;font-size:1rem;line-height:1.4;padding:40px 15px 40px 15px;transition:all .35s ease}.navbar-custom .navbar-nav>li>a:focus,.navbar-custom .navbar-nav>li>a:hover{background:0 0}@media (max-width:991px){.navbar-custom .navbar-nav{letter-spacing:0;margin-top:1px}.navbar-custom .navbar-nav li{margin:0 20px;padding:0}.navbar-custom .navbar-nav li>a{color:#bbb;padding:12px 0 12px 0}.navbar-custom .navbar-nav>li>a:focus,.navbar-custom .navbar-nav>li>a:hover{background:0 0;color:#fff}.navbar-custom li a{border-bottom:1px solid rgba(73,71,71,.3)!important}.navbar-header{float:none}.navbar-collapse{border-top:1px solid transparent;box-shadow:inset 0 1px 0 rgba(255,255,255,.1)}.navbar-collapse.collapse{display:none!important}.navbar-custom .navbar-nav{background-color:#1a1a1a;float:none!important;margin:0!important}.navbar-custom .navbar-nav>li{float:none}.navbar-header{padding:0 130px}.navbar-collapse{padding-right:0;padding-left:0}}@media (max-width:768px){.navbar-header{padding:0 15px}.navbar-collapse{padding-right:15px;padding-left:15px}}@media (max-width:500px){.navbar-custom .navbar-brand{float:none;display:block;text-align:center;padding:25px 15px 12px 15px}}@media (min-width:992px){.navbar-custom .container-fluid{width:970px;padding-right:15px;padding-left:15px;margin-right:auto;margin-left:auto}}@media (min-width:1200px){.navbar-custom .container-fluid{width:1170px;padding-right:15px;padding-left:15px;margin-right:auto;margin-left:auto}} @font-face{font-family:'Open Sans';font-style:normal;font-weight:300;src:local('Open Sans Light'),local('OpenSans-Light'),url(http://fonts.gstatic.com/s/opensans/v17/mem5YaGs126MiZpBA-UN_r8OXOhs.ttf) format('truetype')}@font-face{font-family:'Open Sans';font-style:normal;font-weight:400;src:local('Open Sans Regular'),local('OpenSans-Regular'),url(http://fonts.gstatic.com/s/opensans/v17/mem8YaGs126MiZpBA-UFW50e.ttf) format('truetype')} @font-face{font-family:Roboto;font-style:normal;font-weight:700;src:local('Roboto Bold'),local('Roboto-Bold'),url(http://fonts.gstatic.com/s/roboto/v20/KFOlCnqEu92Fr1MmWUlfChc9.ttf) format('truetype')}@font-face{font-family:Roboto;font-style:normal;font-weight:900;src:local('Roboto Black'),local('Roboto-Black'),url(http://fonts.gstatic.com/s/roboto/v20/KFOlCnqEu92Fr1MmYUtfChc9.ttf) format('truetype')} </style>
</head>
<body class="">
<nav class="navbar navbar-custom" role="navigation">
<div class="container-fluid padding-0">
<div class="navbar-header">
<a class="navbar-brand" href="#">
{{ keyword }}
</a>
</div>
<div class="collapse navbar-collapse" id="custom-collapse">
<ul class="nav navbar-nav navbar-right" id="menu-menu-principale"><li class="menu-item menu-item-type-post_type menu-item-object-post menu-item-169" id="menu-item-169"><a href="#">About</a></li>
<li class="menu-item menu-item-type-post_type menu-item-object-post menu-item-121" id="menu-item-121"><a href="#">Location</a></li>
<li class="menu-item menu-item-type-post_type menu-item-object-post menu-item-120" id="menu-item-120"><a href="#">Menu</a></li>
<li class="menu-item menu-item-type-post_type menu-item-object-post menu-item-119" id="menu-item-119"><a href="#">FAQ</a></li>
<li class="menu-item menu-item-type-post_type menu-item-object-post menu-item-122" id="menu-item-122"><a href="#">Contacts</a></li>
</ul> </div>
</div>
</nav>
<div class="clearfix"></div>
{{ text }}
<br>
{{ links }}
<footer class="site-footer">
<div class="container">
<div class="row">
<div class="col-md-12">
<div class="site-info">
<p>{{ keyword }} 2021</p></div>
</div>
</div>
</div>
</footer>
</body>
</html>";s:4:"text";s:10908:"NICOSIA, May 24 (Xinhua) -- Cyprus' health authorities reported on Monday the country's first case of death of a person who developed blood clotting after receiving the AstraZeneca vaccine against COVID-19. Haiti passed immunization against COVID-19 with the British AstraZeneca vaccine candidate, following scuttlebutts about Government´s alleged rejection, official sources reported. Canada reports first death linked to AstraZeneca jab A test tube labelled "vaccine" in front of an AstraZeneca logo in this illustration taken, Sep 9, 2020. April 17, 2021 17 April 2021 — Sebastian Rushworth M.D. It is unclear whether Australian health … Germany's vaccine regulator said on Tuesday it has recorded 31 cases of a rare blood clot in the brain, nine of which resulted in deaths, after people received a COVID-19 vaccine from AstraZeneca. 127,000 people across the UK have died within 28 days of a positive test for coronavirus. The Paul Ehrlich Institute (PEI) said it has now registered 31 cases of clots in the cerebral veins - known as sinus vein thrombosis, or CSVT - and that in 19 of these there was a deficiency of … The developments take the total Australian reports of cases assessed as TTS following the AstraZeneca vaccine to 18. 7 blood clot deaths linked to AstraZeneca vaccine, report says. UK reports 32 deaths from clots after AstraZeneca vaccine Updated / Thursday, 22 Apr 2021 20:25 It represents a rise of 10 deaths compared to the period up to … The AstraZeneca vaccine was first authorized for use in Europe at the end of January, then rolled out slowly in February. (AP pic) HANOI: Vietnam’s health ministry today reported its first death … Follow DW for the latest. COVID-19 Vaccine AstraZeneca is a vaccine for preventing coronavirus disease 2019 (COVID-19) in people aged 18 years and older. Denmark Reports One Death After Use of AstraZeneca Vaccine, Will Maintain Suspension. Elena Panagiotopoulou, Deputy Director of … The deaths are linked to a rare blood-clotting syndrome known as … Dr. Jennifer Russell, the … MONTREAL, April 27 (Reuters) - … The Quebec Health Ministry has confirmed the death of a woman in the province after the AstraZeneca-Oxford COVID-19 vaccine she received in early April led to a rare blood clot in her brain. Health authorities estimate the syndrome affects four to six cases per 1 million AstraZeneca vaccine recipients, but it can cause a death rate of up to 25% when it occurs. COVID-19 is caused by SARS-CoV-2 virus. 'Yes, Haiti has passed it!' About 1.8 million doses of the AstraZeneca vaccine have been administered so far. It is the second reported death from vaccine-induced immune thrombotic thrombocytopenia or VITT linked to the AstraZeneca vaccine in … SYDNEY: Australia on Friday reported its first fatality from blood clots in a recipient of AstraZeneca 's Covid-19 shot, and its regulator said there was a likely link between the 48-year-old woman's death and the vaccine. In a press statement, the Drug and Food Monitoring Agency concluded that the vaccine batch "meets quality requirements and is safe to use." LONDON (REUTERS) - Data from the rollout of AstraZeneca's Covid-19 vaccine shows one dose of the shot results in 80 per cent less risk of death from the … The 48-year-old woman was injected with the vaccine on April 8. THE CHANCE of developing a deadly blood clot from the AstraZeneca Covid jab is just 0.00015 per cent, new figures reveal. In the UK, the vaccine has been approved for use in … MONTREAL — The province of Quebec on Tuesday reported Canada’s first death of a patient from a rare blood clot condition after receiving the AstraZeneca COVID-19 vaccine. The family of the deceased has blamed the vaccine for causing his death but a lack of postmortem examination makes it unlikely to verify the claim. Thrombosis is a possible complication of the AstraZeneca vaccine, but experts stress that it is reported in about one per 100,000 vaccines administered, which amounts to a … The province of Quebec on Tuesday reported Canada's first death of a patient from a rare blood clot condition after receiving the AstraZeneca COVID-19 vaccine. Shares of AstraZeneca, a front-runner in the Covid-19 vaccine race, gave up a slight gain after the news broke. While 21.2million Brits have had the Oxford vaccine, 168 rare blood … BRUSSELS (AP) - The European Union took on vaccine producer AstraZeneca in a Brussels court on Wednesday with the urgent demand that the company needs … Seven people have died from unusual blood clots after getting the Oxford-AstraZeneca vaccine in the UK, the medicines regulator has confirmed … Hers was the third instance of the rare blood clots appearing in people who have been administered the vaccine in Australia. Vietnam's health ministry on Friday reported its first death in a patient who received AstraZeneca's (AZN.L) COVID-19 vaccine shot, as the country is … The Oxford–AstraZeneca COVID-19 vaccine, codenamed AZD1222, and sold under the brand names Covishield and Vaxzevria among others, is a viral vector vaccine for prevention of COVID-19.Developed by Oxford University and AstraZeneca, it is given by intramuscular injection, using as a vector the modified chimpanzee adenovirus ChAdOx1. Earlier this month, prior to his removal from the position leading Canada’s vaccine rollout, Maj.-Gen. Dany Fortin said Canada had between 250,000 and 270,000 AstraZeneca doses expiring in June. EU agency finds AstraZeneca vaccine can cause rare blood clots, as UK advises other shots for under-30s In the UK, there were reports of 79 serious blood … Elena Panagiotopoulou, Deputy Director of … Tuesday night, the … REUTERS/Thanh Hue. Authorities said the woman had received the AstraZeneca vaccine on 8 April, before the government’s announcement that the Pfizer vaccine was preferred for … A 35-year-old Vietnamese woman has died from anaphylactic shock after receiving her first AstraZeneca’s Covid-19 vaccine shot. Denmark has temporarily suspended use of the Oxford-AstraZeneca covid-19 vaccine as a precautionary move after reports of blood clots and one death. Oxford University said it would await additional data from UK authorities before restarting trials of the vaccine. Meanwhile, Brazil has reported a record number of deaths. AstraZeneca said only that it didn't identify any safety concerns related to the vaccine. The covid-19 vaccine that they had hoped would generate an endless tide of goodwill is instead turning in to one long public relations disaster.… Denmark reports a death and a critical illness after 2 AstraZeneca vaccinations, prompting more reviews. (CNN) Quebec's top doctor says a 54-year-old woman has died of a rare blood clotting condition after receiving the AstraZeneca Covid-19 vaccine. Brazilian news outlet Folha de S. Paulo reported that the health ministry was investigating a death in a pregnant woman who received the AstraZeneca COVID-19 vaccine in Rio de Janeiro. The news came as health officials reported fewer than 1,000 new cases of COVID-19 in the province for the second day in a row, with 899 new infections. THE CHANCE of developing a deadly blood clot from the AstraZeneca Covid jab is just 0.00015 per cent, new figures reveal. Shutterstock The Public Health Agency of Canada has confirmed the country’s first COVID-19 vaccine-related death — a 54-year-old Quebec woman who died from blood clot complications after receiving the AstraZeneca vaccine. (Photo: REUTERS/Dado Ruvic) The province of Quebec on Tuesday reported Canada's first death of a patient from a rare blood clot condition after receiving the AstraZeneca COVID-19 vaccine. Hers was the third instance of the rare blood clots appearing in people who have been administered the vaccine in Australia. HANOI (Reuters) -Vietnam's health ministry on Friday reported its first death in a patient who received AstraZeneca's COVID-19 vaccine shot, as the country is battling a new outbreak. Vials of the AstraZeneca Covid-19 vaccine at a regional vaccine … The latest reports from March 12 indicate a total of 15 individuals died after receiving vaccinations. The New Brunswick death is the third reported in Canada of someone dying after taking the AstraZeneca vaccine. ... A health worker prepares a dose of the Astrazeneca vaccine during a COVID-19 … Vietnam is […] Australia on Friday reported its first fatality from blood clots in a recipient of AstraZeneca's COVID-19 shot, and its regulator said there was a likely link between the 48-year-old woman's death and the vaccine. Canada reports first death linked to AstraZeneca jab A test tube labelled "vaccine" in front of an AstraZeneca logo in this illustration taken, Sep 9, 2020. Sandro Tognatti died hours after getting the AstraZeneca COVID-19 vaccine. Various reports indicate that the vaccines cause more injuries and deaths than natural COVID-19 infections. Skip to content THE NEW DARK AGE ONLINE SINCE 1979 MENU IS THE ASTRA-ZENECA VACCINE KILLING PEOPLE? Five new reports of blood clotting linked to AstraZeneca COVID-19 vaccine emerge in Australia, authorities investigating Posted 7 m minutes ago Thu Thursday 6 May May 2021 at 6:33am A 54-year woman has died in Canada after receiving the AstraZeneca Covid vaccine, the first fatality linked to the drug in the country, provincial authorities announced Tuesday. William Pape, co-chair of the National Multisectoral Commission for … Facebook So far, officials have insisted there has yet to be a direct link between Tognatti’s death and his shot. The AstraZeneca vaccine is the most widely used jab in the UK, with over 27 million doses given so far. PHE said the data shows that protection against mortality from the Pfizer vaccine is even higher – about 69 percent – for those who had done their second jab at least seven days before testing positive for the virus. While 21.2million Brits have had the Oxford vaccine, 168 rare blood clots have been recorded - and of those, 32 people have died, UK regulators said. by Sebastian Rushworth, M.D. Shares of AstraZeneca, a front-runner in the Covid-19 vaccine race, gave up a slight gain after the news broke. Indonesian authorities said Tuesday there is no plan to suspend the use of AstraZeneca vaccine amid reports that a man in East Jakarta died one day after receiving the first jab of the UK vaccine. Shares were down by about 1% in early afternoon trading. Coronavirus: 438 new cases reported as HSE indicates people in 40s will not get AstraZeneca or Janssen vaccines Paul Reid says almost 300,000 people in the State will be vaccinated in … Covid-19 vaccines have been linked with blood clots in Europe and the UK, although health authorities there have said the benefits of the vaccine outweigh the risks. (Photo: REUTERS/Dado Ruvic) The country is reporting an average of 281,386 new cases and 4,106 deaths … ";s:7:"keyword";s:33:"astrazeneca vaccine death reports";s:5:"links";s:1262:"<a href="http://digiprint.coding.al/site/go8r5d/roman-coins-for-beginners">Roman Coins For Beginners</a>,
<a href="http://digiprint.coding.al/site/go8r5d/insider-trading-scandal-2019">Insider Trading Scandal 2019</a>,
<a href="http://digiprint.coding.al/site/go8r5d/markel-insurance-reddit">Markel Insurance Reddit</a>,
<a href="http://digiprint.coding.al/site/go8r5d/change-default-messaging-app-android">Change Default Messaging App Android</a>,
<a href="http://digiprint.coding.al/site/go8r5d/bolt-email-address-cape-town">Bolt Email Address Cape Town</a>,
<a href="http://digiprint.coding.al/site/go8r5d/6%2F58-lotto-result-dec-2020">6/58 Lotto Result Dec 2020</a>,
<a href="http://digiprint.coding.al/site/go8r5d/emmanuelle-pierre-bachelet">Emmanuelle Pierre Bachelet</a>,
<a href="http://digiprint.coding.al/site/go8r5d/is-fidelity-bank-having-network-issues-today">Is Fidelity Bank Having Network Issues Today</a>,
<a href="http://digiprint.coding.al/site/go8r5d/options-insider-trading">Options Insider Trading</a>,
<a href="http://digiprint.coding.al/site/go8r5d/cakes-that-look-like-hamburgers">Cakes That Look Like Hamburgers</a>,
<a href="http://digiprint.coding.al/site/go8r5d/if-i-were-given-a-chance-grammar">If I Were Given A Chance Grammar</a>,
";s:7:"expired";i:-1;}
Mini Shell